Scarica l'app Stockscreener
0.86
7.46%
-0.0693
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BJDX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.9293
Aprire:
$0.95
Volume 24 ore:
103.03K
Relative Volume:
0.03
Capitalizzazione di mercato:
$889.85K
Reddito:
-
Utile/perdita netta:
$-6.90M
Rapporto P/E:
-0.0614
EPS:
-14.0152
Flusso di cassa netto:
$-6.65M
1 W Prestazione:
-16.50%
1M Prestazione:
-28.33%
6M Prestazione:
-76.24%
1 anno Prestazione:
-85.67%
Intervallo 1D:
$0.86
$0.95
Intervallo di 1 settimana:
$0.83
$1.11
Portata 52W:
$0.83
$16.68
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Nome
Bluejay Diagnostics Inc
Settore
Industria
Telefono
(978) 631-0152
Indirizzo
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
0.86 | 1.14M | 0 | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc Borsa (BJDX) Ultime notizie
Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BJDX|Bluejay Diagnostics Inc|Price:1.030|Chg%:-0.110 - TradingKey
Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bluejay Diagnostics Inc (BJDX) Institutional Confidence - TradingKey
Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bluejay Diagnostics Inc (BJDX) Cash Flow - TradingKey
Bluejay Diagnostics Inc (BJDX) Balance Sheet - TradingKey
Bluejay Diagnostics Inc (BJDX) Income Statement - TradingKey
Bluejay Diagnostics, Inc. Revenue Breakdown – NASDAQ:BJDX - TradingView
Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% owner - Bitget
Form 4 Bluejay Diagnostics Inc For: 22 July By Investing.com - Investing.com South Africa
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study - TipRanks
Bank of America drops below 10% stake in Bluejay Diagnostics, Inc. (BJDX) - Stock Titan
Bluejay Diagnostics, Inc. (BJDX) stock price, news, quote and history - Yahoo Finance UK
Bluejay Diagnostics, Inc. (BJDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of America details Bluejay Diagnostics, Inc. (BJDX) insider stake - Stock Titan
Bluejay completes 750-patient sepsis study - grafa.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study - marketscreener.com
Bluejay completes enrollment in sepsis diagnostic study By Investing.com - Investing.com Nigeria
Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study - TradingView
Bluejay completes enrollment in sepsis diagnostic study - Investing.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Validation Study Ahead of Schedule - Quiver Quantitative
Bluejay's sepsis study enrolls 750 patients ahead of schedule - Stock Titan
What's going on with Bluejay Diagnostics shares on Wednesday? - MSN
HRT FINANCIAL LP Acquires 92,055 Shares in Bluejay Diagnostics I - GuruFocus
BJDX Stock Pulls Back As Volatility Cools And Cash Runway Stands Out - StocksToTrade
BJDX Stock Crafts Tight Range After Big Spike - StocksToTrade
BJDX Stock Pulls Back As Traders Watch Key Support - timothysykes.com
Insider Sell: Financial Hrt Sells Shares of Bluejay Diagnostics Inc (BJDX) - GuruFocus
Form 4 Bluejay Diagnostics Inc For: 13 July By Investing.com - Investing.com Canada
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock - Investing.com
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) holder HRT Financial reports net share buying and selling - Stock Titan
[Form 3] Bluejay Diagnostics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
BJDX Q4 2023 Earnings: Wide EPS Miss and No Revenue, Yet Stock Gains 3.57%Margin Expansion Trends - dars.gov.et
Form 4 Bluejay Diagnostics Inc For: 10 July By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) shows Bank of America entities as 10% owners - Stock Titan
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) sees 8 shares reported by Bank of America - Stock Titan
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Cash Runway - StocksToTrade
BJDX Stock Slides As Traders Gauge Cash Runway And Volatility - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Support Levels - StocksToTrade
BJDX Stock Slides As Traders Study Volatile Chart - timothysykes.com
BJDX Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BJDX Stock Slides As Traders Watch Support Levels - timothysykes.com
Bluejay Diagnostics Inc Azioni (BJDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bluejay Diagnostics Inc Azioni (BJDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Jul 10 '26 |
Sale |
1.40 |
34,938 |
48,913 |
92,055 |
| Wurth Douglas Clark | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,608 |
| Dey Indranil | President and CEO |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,522 |
| CHASE DONALD R | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,525 |
| ZEIDMAN FRED S | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,500 |
| Dey Svetlana | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,501 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):